Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001047469-13-001792
Filing Date
2013-02-27
Accepted
2013-02-27 12:26:57
Documents
14
Period of Report
2012-12-31

Document Format Files

Seq Description Document Type Size
1 10-K a2212857z10-k.htm 10-K 1254852
2 EX-21 a2212857zex-21.htm EX-21 6358
3 EX-23.1 a2212857zex-23_1.htm EX-23.1 5824
4 EX-31.1 a2212857zex-31_1.htm EX-31.1 8016
5 EX-31.2 a2212857zex-31_2.htm EX-31.2 8009
6 EX-32.1 a2212857zex-32_1.htm EX-32.1 4282
7 EX-32.2 a2212857zex-32_2.htm EX-32.2 4288
14 G275715.JPG g275715.jpg GRAPHIC 51574
  Complete submission text file 0001047469-13-001792.txt   11676054

Data Files

Seq Description Document Type Size
8 EX-101.INS cvd-20121231.xml EX-101.INS 1735783
9 EX-101.SCH cvd-20121231.xsd EX-101.SCH 78804
10 EX-101.CAL cvd-20121231_cal.xml EX-101.CAL 95909
11 EX-101.LAB cvd-20121231_lab.xml EX-101.LAB 1470941
12 EX-101.PRE cvd-20121231_pre.xml EX-101.PRE 690322
13 EX-101.DEF cvd-20121231_def.xml EX-101.DEF 421728
Mailing Address COVANCE INC 210 CARNEGIE CENTER PRINCETON NJ 08540
Business Address 210 CARNEGIE CENTER PRINCETON NJ 08540 6094524440
COVANCE INC (Filer) CIK: 0001023131 (see all company filings)

EIN.: 223265977 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-12213 | Film No.: 13645705
SIC: 8731 Services-Commercial Physical & Biological Research